Delivery Order SPE2DB22D2206-SPE2DB24FHH60

Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,279.01 firm fixed price delivery order is for the supply of Carafate 1 GM/10 ML suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,895.76 firm fixed-price delivery order is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp, the prime contractor, has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,178.46 delivery order is for the supply of Carafate 1 GM/10 ML suspension medication, with a completion date of December 3, 2021. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award is for the delivery of Carafate 1 GM/10 ML suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,564.11 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 12, 2021, with a completion date of October 13, 2021. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award, identified as SPE2DX15D3020|SPE2DX24FXJZF, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Carafate 1 gram tablets. The contract has a ceiling value of $12,768.88 and a completion date of December 22, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $34,856.30, is for the supply of 4,556,332,867 units of the prescription medication Carafate 1 GM/10 ML Suspension in 420 ML containers. The delivery order falls under an indefinite delivery contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,246.16 firm fixed-price delivery order is for the supply of 420 milliliters of Sucralfate 1 gram per 10 milliliters suspension to support federal healthcare programs. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAMW8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,909.12 firm fixed-price delivery order is for the supply of 420 mL bottles of 1 gram/10 mL Sucralfate suspension. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The $4,706.94 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,101.89, is for the delivery of 420 ml bottles of 1 gm/10 ml Sucralfate suspension. This is a firm-fixed-price delivery order contract that runs through March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHH60
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (CAGE Code KABZK8W6PQT3) was issued by the Defense Logistics Agency (DLA) on May 21, 2024. The $3,678.86 firm fixed-price delivery order (SPE2DB24FHH60) is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, will be responsible for delivering the requested pharmaceutical product to the specified location in Conshohocken, PA by the ultimate completion date of May 22, 2024.

Generated 5/16/25, 12:08 PM